Skip to main content

Table 3 Final quantitative quality statement and PM results (N = 22)

From: Developing a set of emergency department performance measures to evaluate delirium care quality for older adults: a modified e-Delphi study

Quality Statement (QS) or PM

Round 3

Median

Scores by tertile (%)

Low

Mid

Upper

Screening

 QS 01 (Screen for non-modifiable risk factors): Important

8

0.00

4.55

95.45

 QS 01 (Screen for non-modifiable risk factors): Actionable

8

0.00

0.00

100.00

 PM 01 (Evidence of structures to support screening): Necessary

8

0.00

4.55

95.45

 PM02 (Older adults documented at risk): Necessary

8

0.00

18.18

81.82

 PM03 (Non-modifiable risk factor screen): Necessary

8

0.00

9.09

90.91

 QS 02 (Screen for delirium): Important

9

0.00

0.00

100.00

 QS 02 (Screen for delirium): Actionable

8

0.00

9.09

90.91

 PM 04 (Evidence of 4AT tool availability): Necessary

8

0.00

4.55

95.45

 PM 05 (Screened on arrival): Necessary

8

0.00

13.64

86.36

 PM 06 (Repeat screening every shift): Necessary

9

0.00

27.27

72.73

Diagnosis

 QS 03 (Assess and diagnose): Important

9

0.00

0.00

100.00

 QS 03 (Assess and diagnose): Actionable

9

0.00

4.55

95.45

 PM 07 (Diagnosis documented): Necessary

9

0.00

0.00

100.00

 PM 08 (Diagnosis in discharge summary): Necessary

8.5

0.00

0.00

100.00

Risk Reduction

 QS 04 (Multicomponent risk reduction): Important

9

0.00

0.00

100.00

 QS 04 (Multicomponent risk reduction): Actionable

8

4.55

22.73

72.73

 PM 09 (Evidence of protocol/pathway): Necessary

9

0.00

0.00

100.00

 PM 10 (Clinical risk factor assessment): Necessary

8

0.00

0.00

100.00

 PM 11 (Risk reduction interventions): Necessary

8

0.00

4.55

95.45

 QS 05 (Medication review): Important

9

0.00

0.00

100.00

 QS 05 (Medication review): Actionable

8

0.00

4.55

95.45

 PM 12 (Evidence of medication review tools): Necessary

8

0.00

4.55

95.45

 PM 13 (Medication review completed): Necessary

8

0.00

0.00

100.00

 QS 06 (Reduce unnecessary within-ED transfers): Important

8

4.55

4.55

90.91

 QS 06 (Reduce unnecessary within-ED transfers): Actionable

4

31.82

40.91

27.27

 PM 14 (Number of within-ED transfers): Necessary

6.5

9.09

40.91

50.50

Management

 QS 07 (Identify and treat causes): Important

9

0.00

0.00

100.00

 QS 07 (Identify and treat causes): Actionable

9

0.00

4.55

95.45

 PM 15 (Evidence of protocol/pathway): Necessary

8

0.00

4.55

95.45

 PM 16 (Assess and identify causes): Necessary

8

0.00

0.00

100.00

 QS 08 (Multicomponent management): Important

9

0.00

0.00

100.00

 QS 08 (Multicomponent management): Actionablea

7

9.09

27.27

63.64

 PM 17 (Evidence of protocol/pathway): Necessary

8

0.00

4.55

95.45

 PM 18 (Management plan initiated): Necessary

8

0.00

0.00

100.00

 PM 19 (Evidence of low stimulus care spaces): Necessary

8

0.00

4.55

95.45

 PM 20 (Placed in low stimulus care space): Necessary

8

0.00

13.64

86.36

 QS 09 (Cautious use of antipsychotic medications): Important

9

0.00

0.00

100.0

 QS 09 (Cautious use of antipsychotic medications): Actionable

7

0.00

27.27

72.73

 PM 21 (Evidence of risk of harm if antipsychotic given): Necessary

8

0.00

13.64

86.36

 QS 10 (Communicate with patient and family/carers): Important

9

0.00

0.00

100.00

 QS 10 (Communicate with patient and family/carers): Actionable

8

0.00

18.18

81.82

 PM 22 (Evidence of communication tools): Necessary

8.5

0.00

0.00

100.00

 PM 23 (Evidence of availability in other languages): Necessary

8

0.00

0.00

100.00

 PM 24 (Patient and family/carers given information): Necessary

8

0.00

4.55

95.45

  1. Bolded numbers = consensus criteria met
  2. aMedian tertile change and ≥ 15% change in responses between Round 2 and Round 3 (i.e., meaningful change)